CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 424B4 Offering Prospectus
- D Other Notice of Sales of Unregistered Securities
- CERTNAS Other Certification by the Nasdaq Stock Market
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- S-1/A Offering Registration Statement
- 10-Q Report Quarterly Report
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change · Regulation FD disclosure
Page 45 of 61 · 1,218 filings